Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer. - Wikidata - awgldk - TriplyDB

Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer.

Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer.

http://www.wikidata.org/entity/Q37089016

about

Use of Animal Models in Understanding Cancer-induced Bone Pain The neurobiology of cancer pain.Administration of a tropomyosin receptor kinase inhibitor attenuates sarcoma-induced nerve sprouting, neuroma formation and bone cancer pain.Comparative Effects of Ibandronate and Paclitaxel on Immunocompetent Bone Metastasis Model.Ibandronate: The loading dose concept in the treatment of metastatic bone pain.Emerging factors in the progression of cancer-related pain.Hypernociceptive responses following the intratibial inoculation of RM1 prostate cancer cells in mice.

P2860

Q26785501-EF47B19F-68FD-4E19-9776-C9F687A36FCE Q34167635-5B993635-D475-41DF-BE58-261846450D93 Q34419168-F25F4F7D-A89E-4152-A0F1-D4997503F644 Q36240183-A88208B1-844E-4D8B-95B9-4C132AF93D1D Q36661448-123FA91D-62EE-489A-BE2E-3C65973591B0 Q38826785-88051ACA-8BBD-4834-8A41-928FAAD0229B Q38952610-4AF7FEDE-C1B4-460C-B308-4EAA6A905A43

P2860

Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer.

http://www.wikidata.org/entity/Q37089016

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Intravenous ibandronate rapidl ...... a mouse model of bone cancer.

@en

Intravenous ibandronate rapidl ...... a mouse model of bone cancer.

@nl

type

label

Intravenous ibandronate rapidl ...... a mouse model of bone cancer.

@en

Intravenous ibandronate rapidl ...... a mouse model of bone cancer.

@nl

prefLabel

Intravenous ibandronate rapidl ...... a mouse model of bone cancer.

@en

Intravenous ibandronate rapidl ...... a mouse model of bone cancer.

@nl

P1433

Q37089016-1024655D-4D38-4574-AA8C-EAC12D497D12

P1476

Q37089016-AF8D7472-53FB-476A-8719-F9917411F292

P2093

Q37089016-0EF9D46F-3BE6-46BB-88D6-7A835D4E13F0

Q37089016-12999C8F-5B9D-47B8-AABC-ED90322B7431

Q37089016-27789D70-AA2D-4131-A2F3-3C65CAC49460

Q37089016-4EFC6032-E450-4D94-8A7C-A758D33EEF15

Q37089016-5C9779AD-A62D-4BBE-BBB1-EC7F1782DA84

Q37089016-8B0FFF91-19C0-48C0-9FE3-7196221ADCB6

Q37089016-E8049168-1335-4257-AC15-24A2D71E9114

P2860

Q37089016-0475DCAF-6649-4860-9636-9E391C119610

Q37089016-05AED182-11F6-483A-A99E-77DB913AAE2B

Q37089016-13FE26F8-7B73-4E4B-917B-A251D4B47EDE

Q37089016-172AC50C-4D3C-4ADA-BE78-08E60FDE4A3B

Q37089016-19B65F35-8144-470F-8D58-04A8D98035BC

Q37089016-1C09A640-2D6D-44CD-9B76-45C18AC2E659

Q37089016-22E33D3D-9F1D-472D-9E78-03C99DA91B1D

Q37089016-28D79687-43DF-4F5F-8262-733528CCDD73

Q37089016-3164CF05-BC31-4C7D-983D-ADCF37FDAF0E

Q37089016-3216AB2D-AAE3-4925-AE39-ADD28905BFF7

P304

Q37089016-5D6EF79D-0F35-439F-97EA-340A2EDCA6FB

P31

Q37089016-11FDBBC6-DECA-4961-9DA5-6BA0820A2AD8

P356

Q37089016-7D23C33A-5B15-4026-9393-38DE3EA0F2AA

P433

Q37089016-8FFAF0A8-8A74-4CEE-B1A2-9676CCC404A6

P478

Q37089016-504D17E2-14A1-48C3-8EC2-5CA35DFE88BE

P577

Q37089016-527DA743-E527-402E-B189-9A98349BFDAD

P5875

Q37089016-7D379C35-039F-4F37-8E42-2D6F45275388

P698

Q37089016-EB122819-1EFC-43DE-9C2C-AB75D67522FA

P932

Q37089016-639ABBDF-39D4-4C42-B742-C44C2F6C1F14

P356

J.JPAINSYMMAN.2007.10.005

P1433

Journal of Pain and Symptom Management

P1476

Intravenous ibandronate rapidl ...... a mouse model of bone cancer.

@en

P2093

Frieder Bauss

http://www.w3.org/2001/XMLSchema#string

Joseph R Ghilardi

http://www.w3.org/2001/XMLSchema#string

Kyle G Halvorson

http://www.w3.org/2001/XMLSchema#string

Lucy J Sullivan

http://www.w3.org/2001/XMLSchema#string

Molly A Sevcik

http://www.w3.org/2001/XMLSchema#string

Nathan J Koewler

http://www.w3.org/2001/XMLSchema#string

Patrick W Mantyh

http://www.w3.org/2001/XMLSchema#string

P2860

The capsaicin receptor: a heat-activated ion channel in the pain pathway

A proton-gated cation channel involved in acid-sensing

The acid-sensitive ionic channel subunit ASIC and the mammalian degenerin MDEG form a heteromultimeric H+-gated Na+ channel with novel properties

The cloned capsaicin receptor integrates multiple pain-producing stimuli

Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain.

Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing.

Breakthrough pain: definition, prevalence and characteristics.

Breakthrough pain in cancer patients: pathophysiology and treatment.

Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons.

Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur.

P304

289-303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JPAINSYMMAN.2007.10.005

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5441704

http://www.w3.org/2001/XMLSchema#string

P698

18411018

http://www.w3.org/2001/XMLSchema#string

P932

2638081

http://www.w3.org/2001/XMLSchema#string